Oliveto Joseph's Form 4 filing
Milestone Pharmaceuticals Inc. (MIST) · filed Jan 9, 2026
- Accession no.
- 0001437782-26-000002
- Filed
- Jan 9, 2026
- Trade date
- Jan 7-8, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $97.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oliveto JosephCIK 0001437782 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Common Shares | SSaleDisposed | −500 | $2.25 | −$1,125 | 346,721 | Direct | |
| Jan 8, 2026 | Common Shares | SSaleDisposed | −43,000 | $2.25 | −$96,750 | 303,721 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.